166 related articles for article (PubMed ID: 12827551)
1. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model.
Saab S; Ly D; Nieto J; Kanwal F; Lu D; Raman S; Amado R; Nuesse B; Durazo F; Han S; Farmer DG; Ghobrial RM; Yersiz H; Chen P; Schwegel K; Goldstein LI; Tong M; Busuttil RW
Liver Transpl; 2003 Jul; 9(7):672-81. PubMed ID: 12827551
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
Lin OS; Keeffe EB; Sanders GD; Owens DK
Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
[TBL] [Abstract][Full Text] [Related]
4. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates.
Roberts DN; Arguedas MR; Fallon MB
Liver Transpl; 2007 Feb; 13(2):206-14. PubMed ID: 17205561
[TBL] [Abstract][Full Text] [Related]
7. Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective.
Sarasin FP; Majno PE; Llovet JM; Bruix J; Mentha G; Hadengue A
Hepatology; 2001 May; 33(5):1073-9. PubMed ID: 11343234
[TBL] [Abstract][Full Text] [Related]
8. Increasing incidence and pretransplantation screening of hepatocellular carcinoma.
Everson GT
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S2-10. PubMed ID: 11084078
[TBL] [Abstract][Full Text] [Related]
9. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective.
Sarasin FP; Giostra E; Mentha G; Hadengue A
Hepatology; 1998 Aug; 28(2):436-42. PubMed ID: 9696009
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: gardening strategies and bridges to transplantation.
Gores GJ
Liver Transpl; 2003 Feb; 9(2):199-200. PubMed ID: 12548516
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation.
Ladabaum U; Cheng SL; Yao FY; Roberts JP
Clin Transplant; 2011; 25(2):283-91. PubMed ID: 20156221
[TBL] [Abstract][Full Text] [Related]
13. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model.
Saab S; DeRosa V; Nieto J; Durazo F; Han S; Roth B
Am J Gastroenterol; 2003 Apr; 98(4):763-70. PubMed ID: 12738453
[TBL] [Abstract][Full Text] [Related]
14. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB
Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
Kwon JS; Lu KH
Obstet Gynecol; 2008 Jul; 112(1):56-63. PubMed ID: 18591308
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison.
Mansueto M; Grimaldi A; Torbica A; Pepe G; Giovacchini G; Messa C; Fazio F
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):224-34. PubMed ID: 17538525
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?
Anderson R; Haas M; Shanahan M
Aust N Z J Public Health; 2008 Feb; 32(1):43-52. PubMed ID: 18290913
[TBL] [Abstract][Full Text] [Related]
18. [Imaging in the screening and diagnosis of hepatocellular carcinoma in cirrhosis liver in Tunisia. A series of 30 cases].
Ben Hassine L; Daghfous MH; Mami A; Chammakhi-Jemli C; Zouaoui W; Saddoud W; Miaoui A; Kharrat J; Ghorbal A; Sehili-Briki S
Tunis Med; 2007 May; 85(5):421-6. PubMed ID: 17657932
[TBL] [Abstract][Full Text] [Related]
19. Screening of patients with chronic liver disease for hepatocellular carcinoma by ultrasonography.
Okazaki N; Yoshida T; Yoshino M; Matue H
Clin Oncol; 1984 Sep; 10(3):241-6. PubMed ID: 6206972
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER
Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
